Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ZF2001 Phase III Trial for COVID-19 Prevention
NCT04646590Phase 3Unknown
- Sponsor
- Zhifei Biological
- Start
- Dec 2020
- Primary completion
- Nov 2021
- Modality
- Recombinant Protein Vaccines
- Countries
- 5
01
Overview
A Phase 3 trial of ZF2001 in coronavirus disease 2019 (COVID-19), sponsored by Zhifei Biological. Status: unknown.
02
Drugs
ZF2001
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04646590.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04646590.